(Q33851136)

29 July 2017

1 reference

title

The potential role of gene therapy in the treatment of bladder cancer (English)

1 reference

29 July 2017

0 references

Hsieh JT

1

1 reference

PubMed ID

10696249

29 July 2017

Dinney CP

series ordinal

2

1 reference

PubMed ID

10696249

29 July 2017

Chung LW

series ordinal

3

1 reference

29 July 2017

1 February 2000

1 reference

Urologic Clinics of North America

29 July 2017

1 reference

29 July 2017

27

1 reference

29 July 2017

103-13, ix

1 reference

29 July 2017

1

1 reference

The interferons: a biological system with therapeutic potential in viral infections

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Human adenovirus-host cell interactions: comparative study with members of subgroups B and C.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Why do so many cancer patients fail to respond to interferon therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Accumulation of nuclear p53 and tumor progression in bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Pharmacodynamics of recombinant IFN-beta during long-term treatment of malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Vaccination of tumor cells transfected with the B7-1 (CD80) gene induces the anti-metastatic effect and tumor immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Effects of nIFN beta and rIFN gamma on growth and morphology of two human melanoma cell lines: comparison between two- and three-dimensional culture

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Cytokine therapeutics: lessons from interferon alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Efficient transfer of genes into senescent cells by adenovirus vectors via highly expressed alpha v beta 5 integrin

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Role of interferons in the regulation of cell proliferation, differentiation, and development

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Interferons in malignancy: biological products or biological response modifiers?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Altered Expression of Retinoblastoma Protein and Known Prognostic Variables in Locally Advanced Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Mechanism of interferon beta-induced squamous differentiation and programmed cell death in human non-small-cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Regulation of gene expression in vivo following transduction by two separate rAAV vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Viral vectors for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Pharmacokinetics and pharmacodynamics of recombinant human interferon-beta in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

1 reference

7 January 2021

Identification of p53 gene mutations in bladder cancers and urine samples

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Adenovirus-mediated suicide gene therapy for experimental bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Clinical and laboratory changes induced by alpha interferon in chronic lymphocytic leukemia--a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Current management of invasive and metastatic transitional cell carcinoma of the bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Effects of interferons and other cytokines on tumors in animals: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

The role of thrombospondin-1 in tumor progression and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970238-X

7 January 2021

10.1016/S0094-0143(05)70238-X

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10696249